Skip to main content
ACR Convergence 2025 Main banner
Final Program


Schedule at a Glance
Legend
Presentation Icons
CME
CME
Non-CME
Non-CME
In Person
In Person
On Demand
On Demand
Live Stream
Live Stream
Active Learning
Active Learning
Choose Rheum
Choose Rheum
Emerging Investigator Awardee
Emerging Investigator Awardee
Program: Abstract Session

Systemic Lupus Erythematosus (SLE)
General Topic: Clinical Science

26S30: Abstracts: Systemic Lupus Erythematosus – Treatment I (0801–0806)

Sunday, October 26, 2025
1:00 PM - 2:30 PM Central Time
Location: S103
CE: 0.00

Non-CME In Person On Demand

    Abstract Moderator(s)

  • CA

    Cristina Arriens, MD, MS

    Oklahoma Medical Research Foundation
    Oklahoma City, OK, United States

    Disclosure information not submitted.

  • AS

    Amit Saxena, MD, MSc

    NYU Grossman School of Medicine
    New York, New York, United States

    Disclosure information not submitted.

Please note: This session is not eligible for CME Credits.

Presentations:

  • 1:00 PM - 1:15 PM Central Time
    Achieving Sustained Lupus Low Disease Activity State and Remission with Ianalumab (VAY736) in Patients with Systemic Lupus Erythematosus: A Post Hoc Analysis from a Phase II Study

    Presenting Author: Ed Vital, MD – University of Leeds

  • 1:15 PM - 1:30 PM Central Time
    Remission from cutaneous manifestations of lupus with enpatoran, a first-in-class oral small molecule toll-like receptor 7/8 inhibitor: pooled post-hoc exploratory analysis from a randomized placebo-controlled Phase II study

    Presenting Author: Eric Morand, MD, PhD – Monash University

  • 1:30 PM - 1:45 PM Central Time
    Improved Efficacy and Safety Outcomes in Patients with SLE Treated with Belimumab (BEL) Versus Immunosuppressants (IS), in Addition to Antimalarials (AM) and Glucocorticoids (GC): A Post Hoc Summary of Five Phase 3 Trials

    Presenting Author: Mariele Gatto, MD – University of Turin

  • 1:45 PM - 2:00 PM Central Time
    Comparative Risk of All-Cause Mortality with Belimumab versus Oral Immunosuppressant Use in Patients with Non-Renal Systemic Lupus Erythematosus

    Presenting Author: Grace Haeun Lee, BA – Massachusetts General Hospital

  • 2:00 PM - 2:15 PM Central Time
    Safety and Efficacy of Hydroxychloroquine According to Weight-based Dose: Results of a Global Systematic Review and Meta-analysis

    Presenting Author: Jacquelyn Nestor, MD, PhD – Massachusetts General Hospital

  • 2:15 PM - 2:30 PM Central Time
    Comparative Risk of Infection-Related Complications in Systemic Lupus Erythematosus Patients Treated with Anifrolumab versus Belimumab: A Target Trial Emulation

    Presenting Author: Teng-Chieh Hsu, MD – Wuri Lin Shin Hospital